NO940974L - Benzanilid-derivater som 5-HT1D antagonister - Google Patents

Benzanilid-derivater som 5-HT1D antagonister

Info

Publication number
NO940974L
NO940974L NO940974A NO940974A NO940974L NO 940974 L NO940974 L NO 940974L NO 940974 A NO940974 A NO 940974A NO 940974 A NO940974 A NO 940974A NO 940974 L NO940974 L NO 940974L
Authority
NO
Norway
Prior art keywords
benzanilide derivatives
ht1d antagonists
ht1d
antagonists
benzanilide
Prior art date
Application number
NO940974A
Other languages
English (en)
Norwegian (no)
Other versions
NO940974D0 (no
Inventor
Alexander William Oxford
William Leonard Mitchell
John Bradshaw
John Watson Clitherow
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO940974D0 publication Critical patent/NO940974D0/no
Publication of NO940974L publication Critical patent/NO940974L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO940974A 1991-09-18 1994-03-17 Benzanilid-derivater som 5-HT1D antagonister NO940974L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919119932A GB9119932D0 (en) 1991-09-18 1991-09-18 Chemical compounds
PCT/EP1992/002136 WO1993006084A1 (fr) 1991-09-18 1992-09-14 Derives de benzanilide en tant qu'antagonistes de 5-ht1d
CN93100710A CN1089944A (zh) 1991-09-18 1993-01-09 N-苯甲酰苯胺衍生物

Publications (2)

Publication Number Publication Date
NO940974D0 NO940974D0 (no) 1994-03-17
NO940974L true NO940974L (no) 1994-03-17

Family

ID=36792802

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940974A NO940974L (no) 1991-09-18 1994-03-17 Benzanilid-derivater som 5-HT1D antagonister

Country Status (14)

Country Link
US (1) US5358948A (fr)
EP (1) EP0533267A1 (fr)
JP (1) JPH06107637A (fr)
CN (2) CN1073430A (fr)
AU (2) AU2568792A (fr)
CA (1) CA2078507A1 (fr)
CZ (1) CZ61194A3 (fr)
FI (1) FI941261A (fr)
GB (1) GB9119932D0 (fr)
IL (1) IL103199A0 (fr)
MX (1) MX9205278A (fr)
NO (1) NO940974L (fr)
WO (1) WO1993006084A1 (fr)
ZA (1) ZA927106B (fr)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2276164A (en) * 1993-03-17 1994-09-21 Glaxo Group Ltd Aniline and benzanilide derivatives
WO1995004729A1 (fr) * 1993-08-06 1995-02-16 Smithkline Beecham Plc Derives amides employes comme antagonistes du recepteur 5ht1d
DE69411176T2 (de) * 1993-08-20 1998-11-12 Smithkline Beecham Plc Amide und harnstoffderivate als 5ht1d rezeptor antagonisten
WO1995006637A1 (fr) * 1993-09-03 1995-03-09 Smithkline Beecham Plc Nouveaux derives d'indole et d'indoline en tant qu'antagonistes du recepteur de 5ht1d
WO1995006644A1 (fr) * 1993-09-03 1995-03-09 Smithkline Beecham Plc Derives d'amide en tant qu'antagonistes du recepteur de 5ht1d
JPH09503773A (ja) * 1993-10-19 1997-04-15 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５ｈｔ−１ｄレセプター拮抗剤用のベンズアニリド誘導体
AU1108395A (en) * 1993-12-07 1995-06-27 Smithkline Beecham Plc Heterocyclic biphenylylamides useful as 5ht1d antagonists
JPH09512804A (ja) * 1994-05-06 1997-12-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ１ｄアンタゴニストとして有用なビフェニルカルボキシアミド類
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
US5756496A (en) * 1994-05-28 1998-05-26 Smithkline Beecham P.L.C. Amide derivatives having 5HT1D-antagonist activity
FR2722788B1 (fr) * 1994-07-20 1996-10-04 Pf Medicament Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
GB9416972D0 (en) * 1994-08-23 1994-10-12 Smithkline Beecham Plc Carbon side chain/indole/indolene
US5972951A (en) * 1994-12-22 1999-10-26 Smithkline Beecham Plc Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists
GB9507203D0 (en) * 1995-04-07 1995-05-31 Smithkline Beecham Plc Novel compounds
FR2740134B1 (fr) * 1995-10-18 1998-01-09 Pf Medicament Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant
ZA9756B (en) * 1996-01-16 1997-07-17 Warner Lambert Co Process for preparing 4,6-disubstituted pyrido[3,4-d]-pyrimidines
FR2744449B1 (fr) * 1996-02-02 1998-04-24 Pf Medicament Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
FR2744450A1 (fr) * 1996-02-02 1997-08-08 Pf Medicament Nouvelles naphtylpiperazines derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
SE9601110D0 (sv) 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
GB9606396D0 (en) * 1996-03-27 1996-06-05 Smithkline Beecham Plc Novel compounds
US6156783A (en) * 1996-04-30 2000-12-05 Smithkline Beecham P.L.C. Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
GB9625145D0 (en) * 1996-12-03 1997-01-22 Smithkline Beecham Plc Novel compounds
CA2274055A1 (fr) * 1996-12-19 1998-06-25 Smithkline Beecham P.L.C. Derives du n-piperazine-1-ylphenyl-benzamide
DZ2376A1 (fr) * 1996-12-19 2002-12-28 Smithkline Beecham Plc Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
FR2761064B1 (fr) * 1997-03-20 1999-06-04 Pf Medicament Piperazines derivees d'amines cycliques, leur preparation et leur application comme medicaments
BR9809092A (pt) * 1997-04-18 2002-01-22 Smithkline Beecham Plc Derivados de indol tendo atividade combinada de antagonista de receptor de 5ht1a, 5ht1b e 5ht1d
SE9900190D0 (sv) 1999-01-22 1999-01-22 Astra Ab New compounds
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds
EP1003738B1 (fr) * 1997-08-09 2003-11-19 SmithKline Beecham plc Composes bicycliques servant de ligands pour les recepteurs 5-ht1
SE9703376D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
SE9703375D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
GB9818914D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Use
GB9826412D0 (en) 1998-12-03 1999-01-27 Glaxo Group Ltd Chemical compounds
US6365591B1 (en) 1999-10-18 2002-04-02 Recordati, S.A., Chemical And Pharmacueticals Company Isoxazolecarboxamide derivatives
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
SE9904724D0 (sv) 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
SE9904723D0 (sv) 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission II
GB2362826A (en) * 2000-06-02 2001-12-05 Lilly Co Eli A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JP4119114B2 (ja) * 2001-11-28 2008-07-16 広栄化学工業株式会社 新規なジヒドロキシ（３−ピリジル）ボラン類
AU2003299797A1 (en) * 2002-12-19 2004-07-14 Neurogen Corporation Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
EP1610753A4 (fr) * 2003-02-20 2007-07-04 Encysive Pharmaceuticals Inc Antagonistes du recepteur de l'urotensine-ii de la phenylenediamine et antagonistes du ccr-9
US7288538B2 (en) 2003-02-20 2007-10-30 Encysive Pharmaceuticals, Inc. Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
DE602004017481D1 (de) 2003-09-22 2008-12-11 Euro Celtique Sa Zur behandlung von schmerzen geeignete therapeutische mittel
EP1664041B1 (fr) 2003-09-22 2008-07-02 Euro-Celtique S.A. Composes phenyl-carboxamide utiles pour traiter la douleur
US7037927B2 (en) * 2003-10-16 2006-05-02 Abbott Laboratories Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor
ES2347152T3 (es) * 2003-11-26 2010-10-26 Pfizer Products Inc. Derivados de aminopirazol como inhibidores de gsk-3.
WO2005073193A1 (fr) * 2004-01-23 2005-08-11 Amgen Inc. Ligands du recepteur vanilloide et leur utilisation dans des traitements
CN1950332A (zh) * 2004-03-02 2007-04-18 神经能质公司 经杂烷基取代的联苯－4－羧酸芳基醯胺类似物
US7851629B2 (en) 2004-06-08 2010-12-14 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
MXPA06013941A (es) 2004-06-08 2007-12-10 Neurosearch Sweden Ab Fenilpiperidinas disustituidas, novedosas, como moduladores de la neurotransmision de dopamina y serotonina.
SE0401465D0 (sv) 2004-06-08 2004-06-08 Carlsson A Research Ab New substituted piperdines as modulators of dopamine neurotransmission
HUE029790T2 (hu) 2004-10-13 2017-04-28 Teva Pharmaceuticals Int Gmbh Eljárás 4-(3-metánszulfonil-fenil)-l-N-propil-piperidin elõállítására
SE529246C2 (sv) 2005-10-13 2007-06-12 Neurosearch Sweden Ab Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
EP2125822B1 (fr) 2006-12-21 2014-11-19 Nerviano Medical Sciences S.R.L. Dérivés de pyrazolo-quinazoline substitués, leur procédé de préparation et leur utilisation en tant qu'inhibiteurs des kinases
KR100851044B1 (ko) * 2007-08-21 2008-08-12 (주)아모레퍼시픽 미백효과를 나타내는 3,5-디히드록시 벤즈아미드 유도체,및 이를 함유하는 화장료 조성물
WO2009152356A2 (fr) * 2008-06-11 2009-12-17 Irm Llc Composés et compositions utiles pour le traitement de la malaria
WO2011057416A1 (fr) * 2009-11-13 2011-05-19 Packers Plus Energy Services Inc. Outil à étages pour cimentation de forage de puits
US8846671B2 (en) * 2010-07-01 2014-09-30 Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof
EP2787997A4 (fr) 2011-12-08 2015-05-27 Ivax Int Gmbh Bromhydrate de pridopidine
EA027748B1 (ru) 2012-04-04 2017-08-31 Тева Фармасьютикалз Интернэшнл Гмбх Применение придопидина в комбинации с тетрабеназином для лечения двигательных нарушений и ожирения
CN107108581B (zh) * 2014-08-21 2020-06-23 百时美施贵宝公司 作为强效rock抑制剂的回接苯甲酰胺衍生物
CN108219913B (zh) * 2018-02-27 2021-07-20 浙江绿保再生资源科技有限公司 一种复合絮凝剂及废润滑油絮凝再生工艺
WO2020183011A1 (fr) 2019-03-14 2020-09-17 Institut Curie Inhibiteurs de htr1d et leurs utilisations dans le traitement du cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3192213A (en) * 1962-10-12 1965-06-29 Olin Mathieson Aminoalkyl anilides
DE1668723A1 (de) * 1966-09-16 1971-04-08 Toyo Jozo Kk Verfahren zum Herstellen von Verbindungen mit Saeureamid-Bindung
AU499714B2 (en) * 1974-10-14 1979-05-03 Chugai Seiyaku Kabushiki Kaisha Bis(benzamido)-benzene derivatives & process for preparing thesame
US4058523A (en) * 1974-10-14 1977-11-15 Chugai Seiyaku Kabushiki Kaisha Bis(benzamido)-benzene derivatives
DE3100575A1 (de) * 1981-01-10 1982-09-02 Dr. Karl Thomae Gmbh, 7950 Biberach "neue benzoesaeuren, ihre herstellung und ihre verwendung als arzneimittel"
US4735959A (en) * 1981-01-10 1988-04-05 Dr. Karl Thomae Gmbh Carboxylic acid amides and pharmaceutical compositions containing them
US4562201A (en) * 1982-07-26 1985-12-31 American Hospital Supply Corporation Aminomethyl benzanilides
US4778796A (en) * 1985-07-19 1988-10-18 Dainippon Pharmaceutical Co., Ltd. ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same
JPH0813759B2 (ja) * 1986-09-01 1996-02-14 富士写真フイルム株式会社 アルコキシベンゼン誘導体の製造方法
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
EP0324521A3 (fr) * 1988-01-11 1991-11-27 Duphar International Research B.V Méthode de traitement des maladies hématologiques et compositions pharmaceutiques pour cet usage
DE68903263T2 (de) * 1988-10-10 1993-05-19 Akzo Nv Substituierte aromatische verbindungen mit zentraler nervensystem-wirkung.

Also Published As

Publication number Publication date
MX9205278A (es) 1993-03-01
GB9119932D0 (en) 1991-10-30
JPH06107637A (ja) 1994-04-19
AU2568792A (en) 1993-04-27
WO1993006084A1 (fr) 1993-04-01
CZ61194A3 (en) 1994-11-16
NO940974D0 (no) 1994-03-17
US5358948A (en) 1994-10-25
FI941261A0 (fi) 1994-03-17
EP0533267A1 (fr) 1993-03-24
IL103199A0 (en) 1993-02-21
ZA927106B (en) 1994-03-17
AU2452892A (en) 1993-03-25
CN1089944A (zh) 1994-07-27
CA2078507A1 (fr) 1993-03-19
FI941261A (fi) 1994-03-17
CN1073430A (zh) 1993-06-23

Similar Documents

Publication Publication Date Title
NO940974L (no) Benzanilid-derivater som 5-HT1D antagonister
DK0533268T3 (da) Benzanilidderivater som 5HT-1D antagonister
DK0516349T3 (da) 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
NO923617D0 (no) Benzanilid-derivater
FI933167A (fi) N-alkylkinuklidiniumsalter som substans-p antagonister
DK0514667T3 (da) Benzazepinderivater som vasopressinantagonister
MX9205145A (es) Nuevos derivados heterociclicos.
NO953406D0 (no) Pyrrolo-pyridinderivater
DE69208877D1 (de) Chinuclidinderivate
NO922182D0 (no) Krystallinske oksatiolan-derivater
FI921182A (fi) Velangummi som snabbt hydratiseras
FI982185A0 (fi) Vesiliukoiset kamtotesiinijohdokset
NO920675D0 (no) Sementadditiv, fremgangsmaate for fremstilling av additivet, samt sement som inneholder additivet
FI961628A0 (fi) Indolijohdannaisia NMDA-antagonisteina
FI925763A (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
FI921133A (fi) Faktor, som stimulerar neu-receptorn
FI925044A0 (fi) Foerfarande foer aotervinning av svavelsyra ur svavelsyraavfall som innehaoller metallsulfat
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
FI925469A (fi) Tiazolylsubstituerade kinolylymetoxifenylaettiksyraderivat
NO942775D0 (no) 3-fenylureido-azepin-2-oner og -benzazepin-2-oner anvendelige som cholecystokinin-antagonister
FI923555A (fi) Foerfarande foer framstaellning av mattor som bestaor av minst tvao med varandra bundna skikt
FI930342A (fi) Pentapeptider som reglerar immun- och nervsystem
KR930702353A (ko) 2- 카르바페넴 유도체
DE69227554D1 (de) Indolinospirobenzopyran-derivate
FI914768A (fi) Foer stoedmurar laempad staolprofil med kantig sammanfogning som arbetsoeppning